Key facts
- BEKHealth’s last known valuation is $23.0M (Feb 2025).
- It has raised $15.7M across 4 recorded rounds; the latest was Seed Round ($3.6M) in Sep 2024.
- Notable investors include Connecticut Innovations, Hatteras Venture Partners, Martin Ventures, Boston Millennia Partners, Change Healthcare — 9 tracked in total.
- BEKHealth has filed 4 Form Ds with the SEC since 2021, most recently Sep 2024 ($3.6M sold to 13 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for BEKHealth
Funding rounds
4 roundsAbout BEKHealth
Developer of clinical research software designed to accelerate timelines by automating multiple impact processes. The company's software provides complete rapid trial feasibility, electronic medical record data processing, feasibility and site selection, precision patient trial matching and care coordination, enabling clients to reduce cost increase enrollment and streamline the clinical research process.
- Sector
- Healthcare
- HQ
- Branford, CT, United States
- Founded
- 2016
- Employees
- 31
- Website
- bekhealth.com/
- Ownership
- Privately Held (backing)
BEKHealth doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BEKHealth shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BEKHealth in its N-PORT filings yet. We sweep new filings monthly.